Company Profile

Navidea Biopharmaceuticals Inc (AKA: Neoprobe Corporation)
Profile last edited on: 9/15/22      CAGE: 085F3      UEI: GQWFJQX2UKJ2

Business Identifier: Precision immunodiagnostic agents and immunotherapeutics for patients with cancer, autoimmune, and infectious diseases
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4995 Bradenton Avenue Suite 240
Dublin, OH 43017
   (614) 793-7500
Location: Single
Congr. District: 12
County: Franklin

Public Profile

Navidea Biopharmaceuticals, Inc. (AMEX: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radio-pharmaceutical agents. Doing business until January 2012 as Neoprobe Corporation, the company is organized around two areas of emphasis - Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages; and NAV4694, a fluorine-18 labeled positron emission tomography imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of Alzheimers disease and mild cognitive impairment. It is also developing NAV5001, an iodine-123 labeled single photon emission computed tomography imaging agent that is used as an aid in the diagnosis of Parkinson's disease and other movement disorders with potential use as a diagnostic aid in dementia; diagnostic substances, including technetium 99m tilmanocept and other diagnostic applications of its Manocept platform; and therapeutic development programs, such as therapeutic applications of its Manocept platform, as well as various development programs.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Jed A Latkin -- CEO, COO, CFO & Director

  Bonnie Abbruzzese -- Senior Director Clinical Research

  David S Casebier -- Vice President, Chemistry, Manufacturing and Controls

  Michael Cop

  Frederick Oliver Cope -- SVP-Pharmaceutical Research & Clinical Development

  Michael Cope

  Erika Gibson -- Director of Fin. & Admin

  Rick J Gonzalez -- former President and Chief Executive Officer

  Stephen B Haber -- Vice President, Development

  Joel H Kaufman -- Chief Business Officer

  Suzanne Elizabeth Lapi

  Brent Larson -- Senior Vice President and CFO

  Mark Marmur -- Media Contact

  Mark Pykett -- Former CEO

  David A Ralph

  William Regan -- Chief Compliance Officer

  Cornelia B Reininger -- Senior VP and Chief Medical Officer

  Michael Stanley Rosol -- Chief Medical Officer and Senior VP

  Jeffrey Smith -- Director of Corporate Development

  Thomas H Tulip -- President and Chief Business Officer